Use of monoclonal antibody therapy for nosocomial SARS-CoV-2 infection in patients at high risk for severe COVID-19: experience from a tertiary-care hospital in Germany
Johanna Koehler, Barbara Ritzer, Simon Weidlich, Friedemann Gebhardt, Chlodwig Kirchhoff, Jens Gempt, Christiane Querbach, Dieter Hoffmann, Bernhard Haller, Roland M. Schmid, Jochen Schneider, Christoph D. Spinner, Roman Iakoubov
Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung
8Zitate
(Scopus)
Fingerprint
Untersuchen Sie die Forschungsthemen von „Use of monoclonal antibody therapy for nosocomial SARS-CoV-2 infection in patients at high risk for severe COVID-19: experience from a tertiary-care hospital in Germany“. Zusammen bilden sie einen einzigartigen Fingerprint.